Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Kyle E. Smoot"'
Autor:
Karen Aboody, Olubankole Aladesuyi Arogundade, Giovanni Appendino, Weiqi Bao, Marco A.S. Baptista, Danielle Beaulieu, Frank Bennett, Emma Brand, Don Cleveland, Stanley L. Cohan, Jonavelle Cuerdo, Jim DeMesa, David L. Ennist, Meryem Guler, Nada Hindiyeh, Hanna Hovren, Yiyun Henry Huang, Hongmei Jia, Jie Jiang, Brian K. Kaspar, Petra Kaufmann, Randall Kaye, Jeffery W. Kelly, Mike Keymer, Doo Yeon Kim, Kiren Kresa-Reahl, Ikjae Lee, Melanie Leitner, Stefanie N. Linch, Elisabeth B. Lucassen, Timothy Miller, Rachael Mooney, Gaetano Morello, Eduardo Muñoz, Michael Murray, Hoi Wa Ngai, Joseph Park, Dustin Pierce, Jana Portnow, Evan T. Powers, Luisa Quinti, John Ravits, Meghan Romba, Rajesh Sampath, S. Pablo Sardi, Mark Schactman, Mohammad Shahnawaz, Richard A. Smith, Kyle E. Smoot, Claudio Soto, Clive N. Svendsen, Soshana P. Svendsen, Rudolph E. Tanzi, Albert A. Taylor, Gil I. Wolfe, Clinton B. Wright, Gerald Yakatan, Neta Zach
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bc3421a84af02dbf2e438ec95985c79e
https://doi.org/10.1016/b978-0-12-816475-4.09992-4
https://doi.org/10.1016/b978-0-12-816475-4.09992-4
Publikováno v:
Biomedicines
Biomedicines, Vol 8, Iss 227, p 227 (2020)
Biomedicines, Vol 8, Iss 227, p 227 (2020)
Sphingosine-1-phosphate (S1P), via its G-protein-coupled receptors, is a signaling molecule with important regulatory properties on numerous, widely varied cell types. Five S1P receptors (S1PR1-5) have been identified, each with effects determined by
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0287e13f3e6ca468663a506ee56cfd01
https://pubmed.ncbi.nlm.nih.gov/32708516
https://pubmed.ncbi.nlm.nih.gov/32708516
Publikováno v:
International Journal of MS Care; 2021 Supplement, Vol. 23, pI-81, 82p
Publikováno v:
International Journal of MS Care; 2018, Vol. 20 Issue Supp1, p1-95, 95p
Publikováno v:
Multiple Sclerosis Journal; 2015 Supplement, p76-653, 578p
For the first time in history, there is now hope for treating neurological disorders that had previously been considered untreatable. The remarkable confluence of events that has heralded this is the focus of Neurotherapeutics in the Era of Translati